Target intelligence / Profile preview

Bacterial 70S ribosome (70S ribosome)

Target
70S ribosome
Molecular classification
Ribosome, Ribonucleoprotein complex, Macromolecular complex, Enzyme (peptidyl transferase activity), Other
01

Overview

The **bacterial 70S ribosome** is a large ribonucleoprotein complex essential for protein synthesis in all bacteria. It consists of two major subunits, the small 30S subunit and the large 50S subunit; together, these catalyze the translation of messenger RNA (mRNA) into proteins. The 70S ribosome derives its name from its sedimentation coefficient in Svedberg units. The 30S subunit mediates mRNA decoding and contains the 16S rRNA and about 21 proteins, while the 50S subunit orchestrates peptide bond formation and includes the 23S and 5S rRNA plus about 33 proteins. The catalytic core of the ribosome is RNA-based (ribozyme activity). The ribosome has multiple binding sites for tRNA (A, P, and E sites) and is the target for numerous clinically important antibiotics, which exploit structural differences between prokaryotic and eukaryotic ribosomes to selectively inhibit bacterial protein synthesis. Structural studies of the bacterial 70S ribosome have provided insights into phylogenetic diversity, antibiotic binding, and conformational dynamics critical for its function and for antibiotic mechanism-of-action development[1][2][4][5][6][8].

Other names
prokaryotic 70S ribosomebacterial ribosome70S ribosomal complexprokaryotic ribosome
02

Mechanism of action

Inhibition of mRNA decoding; Blockade of peptide bond formation; Prevention of translocation along mRNA; Disruption of tRNA binding or movement; Induction of ribosomal conformational changes to arrest protein synthesis[7][1]

03

Biological functions

Protein synthesismRNA translationPolypeptide chain elongationDecoding of genetic informationPeptide bond formationOther
04

Disease associations

Infection (therapeutic target for antibacterial drugs)Other
05

Safety considerations

Broad inhibition of bacterial protein synthesis can disrupt normal microbiotaRisk of cross-reactivity or unintended inhibition of mitochondrial ribosomes (as they are structurally similar to bacterial ribosomes), leading to mitochondrial toxicityEmergence of antibiotic resistance via ribosomal mutations or drug effluxOther
06

Interacting drugs

Aminoglycosides (e.g., paromomycin, amikacin)

6 more in the full profile.

Beyond the preview

Go deeper on Bacterial 70S ribosome (70S ribosome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 70S ribosome (70S ribosome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call